Upgrade to SI Premium - Free Trial

BNP Paribas Exane Downgrades Organon & Co. (OGN) to Neutral Post Acquisition

April 28, 2026 6:17 AM

BNP Paribas Exane analyst Navaan Ty downgraded Organon & Co. (NYSE: OGN) from Outperform to Neutral.

For an analyst ratings summary and ratings history on Organon & Co. click here. For more ratings news on Organon & Co. click here.

Shares of Organon & Co. closed at $13.16 yesterday.

Categories

Downgrades

Next Articles